Filed Jan. 30, 2020

Serial No. 88779673

Examining Attorney REBECCA D. COUGHLAN

Class Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, acellular vaccines, protein-based vaccines, conjugated vaccines, and vaccines generated in an in vitro cell-free expression system; Research and development in the field of bioinformatics and production of proteins in cell-free expression systems for the development of vaccines; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use, namely, new vaccines for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics for the treatment of viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development onto the biosynthetic pathways involved in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development onto the biosynthetic pathways and their evolution in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the fields of bioinformatic-derived drug discovery; Research and development of software-based platforms for the identification of novel therapeutic drug compounds, namely, software-based platforms for collecting, identifying, and searching collections of natural products and/or biosynthesis pathways and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Services in the filed of therapeutic drug discovery, namely, providing data processing software services, in the fields of pharmaceutical, biomedical, medical and clinical research and drug discovery; Services in the filed of therapeutic drug discovery, namely, providing software services for the identification of novel therapeutic drug compounds, namely, software services for collecting, identifying, and searching collections of the biosynthetic pathways and their products and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein-based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses; 100; 101